Advances in Viral Hepatitis B and D: Moving Toward the Goals of Elimination., An Issue of Clinics in Liver Disease

Robert G. Gish, a renowned expert in Hepatitis B and Hepatitis D, edits this issue of Clinics in Liver Disease, providing up-to-date clinical summaries on advances in HBV viro-immunology, novel assays, new targets, and tests for HBV and HDV. It covers 13 relevant topics and offers in-depth clinical reviews, offering actionable insights for clinical practice.

Format: Hardback
Length: 240 pages
Publication date: 04 October 2023
Publisher: Elsevier - Health Sciences Division

In this issue of Clinics in Liver Disease, esteemed guest editor Robert G. Gish brings his extensive expertise to the forefront, delving into the realms of Hepatitis B and Hepatitis D. The articles presented herein offer comprehensive clinical summaries of the latest advancements in these liver diseases, with a particular focus on HBV viro-immunology, novel assays, emerging targets, and innovative tests for HBV and HDV. Spanning 13 relevant and practice-oriented topics, this edition encompasses a diverse range of subjects, including:

Novel Assays to Solve the Clinical and Scientific Challenges of Chronic Hepatitis B: This section explores innovative approaches and technologies that aim to enhance our understanding and management of chronic hepatitis B. It discusses novel assays that can accurately detect and quantify HBV infection, as well as novel therapies and interventions that target the virus.

Maternal-to-Child Transmission of Hepatitis B Virus and Hepatitis Delta Virus: Understanding the transmission of HBV and HDV from mother to child is crucial in preventing and managing these diseases. This section provides in-depth clinical reviews, highlighting the risk factors, clinical manifestations, and management strategies for maternal-to-child transmission.

Triple Threat: HDV, HBV, HIV Coinfection: The co-infection of HDV, HBV, and HIV poses unique challenges and complexities in the management of liver diseases. This section explores the clinical presentation, diagnosis, treatment, and outcomes of triple threat infections, emphasizing the importance of comprehensive care and multidisciplinary approaches.

Targeting Hepatitis B Virus DNA Using Designer Gene Editors: Designer gene editors, such as CRISPR-Cas9, hold immense potential for the treatment and prevention of HBV infection. This section delves into the latest research and applications of designer gene editors in HBV therapy, highlighting their potential benefits and limitations.

And many more!

In addition to the clinical summaries, this issue also features in-depth clinical reviews that provide actionable insights for clinical practice. Authored by esteemed experts in the field, these reviews synthesize and distill the latest research and practice guidelines, offering clinically significant and topic-based reviews.

Clinics in Liver Disease is a renowned publication, and this issue under the guidance of experienced editors in the liver disease domain, ensures that readers are provided with the most up-to-date and authoritative information on Hepatitis B and Hepatitis D. The authors have meticulously compiled and reviewed the literature, ensuring that the content is accurate, evidence-based, and relevant to clinical practice.

Whether you are a healthcare professional, researcher, or patient, this issue of Clinics in Liver Disease is a valuable resource for staying informed and up-to-date on the latest advancements in liver disease management. So, take advantage of this opportunity to expand your knowledge and expertise in this field.

Weight: 450g
ISBN-13: 9780323939478